AI Overview

Cette DP invite à soumettre des propositions pour la fourniture de produits d'oncologie et d'injectables divers PH avec un échéancier de février 2026, couvrant des produits pharmaceutiques injectables et des produits d'oncologie, y compris des articles médicalement nécessaires.

Information de base

Numéro de Référence

00004893594

Organisation émettrice

Mohawk Medbuy Corporation

Type d’appel d’offres

APM - Avis de projet de marché (Formel)

Numéro d’appel d’offres

AB-2026-01010

Titre

CW24810 PH MISCELLANEOUS ONCOLOGY + INJECTABLES FEBRUARY 2026 - RFP

Code d’identité d’origine

SCRIBE

Détails

Emplacement

Alberta

Type d’achat

Non-mentionné

Dates

Publication

2026-02-06 11h31:00 HNE

Date de fermeture

2026-03-04 14h00:00 HNE

Information du contact

Marsha Van Groningen

mvangroningen@mohawkmedbuy.ca

Description

This Request for Proposal (RFP) is an invitation from Mohawk Medbuy Corporation (hereinafter referred to as “Mohawk Medbuy”) to prospective Sellers (hereinafter referred to as “Proponent(s)”) to submit proposals for the provision of PH MISCELLANEOUS ONCOLOGY + INJECTABLES FEBRUARY 2026. Potential Proponent(s) must be able to meet or exceed all the requirements of this RFP for Single or Split Award, by Product or Product family, or Reserve Award as applicable to the Product for the following categories:

PH INJECTABLE PHARMACEUTICALS
PH MEDICALLY NECESSARY INJECTABLE PHARMACEUTICALS
PH PHARMACEUTICALS ONCOLOGY
PH MEDICALLY NECESSARY INJECTABLES ONCOLOGY

Afficher davantage

Dérogation All amendments to the associated notice, including amended documents, plans and specifications (where applicable), are issued on purchasing.alberta.ca. MERX asks that you refer to the purchasing.alberta.ca notice for these amendments. MERX stipulates that potential bidders may also be required to register with the buying authority as a bidder/plan taker. The contact information can be found within the notice abstract.